Vimian Group AB (VIMGF)

Market Closed

7 Aug, 20:00

OTC PINK

2. 77

1.46B Market Cap

- P/E Ratio

- Div Yield

7,000 Volume

0.81 Eps

$ 2.77

Previous Close

Add Transaction

Day Range

2.68 2.77

Year Range

2.68 4.3

Want to track VIMGF and more in your Portfolio? 🎯

Get Started For Free

Summary

VIMGF closed Friday higher at $2.77, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, VIMGF stock gained 3.3582%.

VIMGF is not paying dividends to its shareholders.

The last earnings report, released on Apr 29, 2026, missed the consensus estimates by -0.03%. On average, the company has fell short of earnings expectations by -0.013%, based on the last three reports.

Vimian Group AB has completed 1 stock splits, with the recent split occurring on May 13, 2024.

The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XSTO (SEK).

VIMGF Chart

Vimian Group AB (VIMGF) FAQ

What is the stock price today?

The current price is $2.77.

On which exchange is it traded?

Vimian Group AB is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is VIMGF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.46B.

Has Vimian Group AB ever had a stock split?

Vimian Group AB had 1 splits and the recent split was on May 13, 2024.

Vimian Group AB Profile

Professional Services Industry	Industrials Sector	Mr. Alireza Tajbakhsh CEO	OTC PINK Exchange	SE0015961982 ISIN
SE Country	1,300 Employees	- Last Dividend	14 Mar 2024 Last Split	- IPO Date

Overview

Vimian Group AB (publ), founded in 2020 and based in Stockholm, Sweden, is a global enterprise dedicated to the animal health sector. The company operates across various segments, including Specialty Pharma, MedTech, Diagnostics, and Veterinary Services, offering a comprehensive range of products and solutions designed for preventative care and the management of chronic conditions in animals. Vimian Group AB stands out in the animal health industry by combining proprietary technologies, diagnostics, and treatments with a strong emphasis on both companion animals and livestock, offering cutting-edge solutions to veterinary professionals and animal health markets internationally.

Products and Services

Nextmune Brand
Under the Nextmune brand, Vimian Group offers proprietary diagnostics, along with prescription and non-prescription treatments focused on preventive care and the management of chronic conditions in companion animals. This product range is crucial for pet owners and veterinarians seeking reliable and effective health solutions for pets.
Indical Bioscience Brand
The Indical Bioscience brand is synonymous with molecular and immunodiagnostic solutions tailored for veterinary-specific applications. These advanced diagnostics are instrumental for labs focusing on livestock and companion animal health, helping to ensure the accuracy and efficiency of disease detection and monitoring.
VetFamily Brand
Vimian provides a unique membership-based platform under the VetFamily brand, which emphasizes procurement, online marketing, education, and HR services alongside fostering a community for veterinary clinics. This comprehensive approach aids in the streamlining and enhancement of veterinary operations, positioning VetFamily as a critical resource for veterinary professionals.
Movora Brand
The company also specializes in orthopedic implants through its Movora brand, catering to veterinarians and universities. These high-quality implants are essential for addressing various orthopedic issues, providing both pets and veterinary professionals with reliable solutions for orthopedic care and surgeries.

Contact Information

Address: Riddargatan 19, Stockholm, Sweden, 11457

Phone: 46 7 36 26 88 86

Website: https://vimian.com

Blog Affiliate Program About Terms Privacy Help Contact Us